20/20 Onsite has been named a Silver Winner in the 2025 TITAN Health Awards in Provider & Services - Healthcare for Transforming Healthcare Through Patient-Centric, Point-of-Need Ophthalmic Assessments. This international honor recognizes 20/20 Onsite’s commitment to making healthcare more accessible and impactful through patient-centric, point-of-need ophthalmic solutions.
With hundreds of entries submitted from over 25 countries, the TITAN Health Awards celebrate excellence in healthcare marketing and communications that make a measurable difference in people’s lives. 20/20 Onsite stood out for its proactive approach to engaging patients and streamlining the clinical trial experience through innovative delivery models and patient-centric outreach.
“This recognition reinforces our belief that meeting patients where they are—physically and psychologically—is essential to transforming healthcare,” said Sonali Bloom, CEO of 20/20 Onsite. “Through our Mobile Vision Clinics, proactive communications, and real-time scheduling, we’ve built an experience that not only improves retention and engagement, but also builds trust with our patients and value for our sponsors.”
How 20/20 Onsite is Raising the Bar
20/20 Onsite has redefined what it means to be a healthcare partner in clinical research. By integrating seamlessly with sponsor protocols and leveraging point-of-need eye assessments, the company delivers ophthalmic assessments directly where needed—at the patient's home or clinical trial site. This flexibility eliminates key barriers to trial participation, improves retention, and ensures high-quality data collection across diverse populations.
About TITAN Health Awards
The TITAN Health Awards are an international competition recognizing excellence in healthcare marketing, advertising, and communications. With categories spanning digital campaigns, strategic brand messaging, and innovative patient engagement tools, the awards spotlight global leaders driving change in healthcare.
About 20/20 Onsite
20/20 Onsite is a healthcare services company providing clinical trial solutions that transform vision care delivery by radically improving patient access through state-of-the-art Mobile Vision Clinics. Their integrated point-of-need service delivery platform has taken high-value eye assessment services directly to patients at work, school, neighborhood, and clinical research sites. During the pandemic, 20/20 Onsite began bringing ophthalmic assessments to patients in clinical trials or post-marketing safety surveillance programs nationwide, increasing access to clinical research. They enable and accelerate fundamental trends toward the decentralization of clinical trials.
20/20 Onsite has served over 85,000 patients, including 34 clinical trials, met 100% of screening timelines across their operations, and consistently reports patient NPS scores of over 95.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250416086429/en/
Contacts
Media Contact:
Josh Anderson
Senior Director of Marketing
janderson@2020onsite.com
